Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Favorite
Fang Zhou, MSc
Takeda Pharmaceutical Company, Shanghai, China, China
Poster(s):
P2773 - Effectiveness and Safety of Vonoprazan Treatment on Symptoms in Elderly Patients With Reflux Esophagitis in China: Post Hoc Analysis of the VIEW Study
Monday, October 27, 2025
10:30 AM - 4:00 PM
MT
P2774 - Impact of Patient and Disease Characteristics on the Effectiveness of Vonoprazan in Chinese Patients With Reflux Esophagitis: Post-Hoc Analysis of the Multicenter Prospective VIEW Study
Monday, October 27, 2025
10:30 AM - 4:00 PM
MT
P2775 - Baseline Characteristics of Patients With Reflux Esophagitis Receiving Vonoprazan Treatment in China: Post Hoc Analysis of the VIEW Real-World Study
Monday, October 27, 2025
10:30 AM - 4:00 PM
MT
